- Home
- LCNB vs CATX Comparison
LCNB vs CATX Comparison
Compare LCNB & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCNB
- CATX
- Stock Information
- Founded
- LCNB 1877
- CATX 1983
- Country
- LCNB United States
- CATX United States
- Employees
- LCNB N/A
- CATX N/A
- Industry
- LCNB Major Banks
- CATX Medical/Dental Instruments
- Sector
- LCNB Finance
- CATX Health Care
- Exchange
- LCNB Nasdaq
- CATX Nasdaq
- Market Cap
- LCNB 205.5M
- CATX 239.0M
- IPO Year
- LCNB N/A
- CATX N/A
- Fundamental
- Price
- LCNB $14.78
- CATX $3.19
- Analyst Decision
- LCNB
- CATX Strong Buy
- Analyst Count
- LCNB 0
- CATX 11
- Target Price
- LCNB N/A
- CATX $13.00
- AVG Volume (30 Days)
- LCNB 22.9K
- CATX 1.1M
- Earning Date
- LCNB 10-20-2025
- CATX 11-11-2025
- Dividend Yield
- LCNB 6.02%
- CATX N/A
- EPS Growth
- LCNB 186.06
- CATX N/A
- EPS
- LCNB 1.49
- CATX N/A
- Revenue
- LCNB $86,864,000.00
- CATX $1,235,000.00
- Revenue This Year
- LCNB $0.86
- CATX N/A
- Revenue Next Year
- LCNB $5.93
- CATX N/A
- P/E Ratio
- LCNB $9.80
- CATX N/A
- Revenue Growth
- LCNB 22.73
- CATX N/A
- 52 Week Low
- LCNB $13.34
- CATX $1.60
- 52 Week High
- LCNB $17.92
- CATX $13.19
- Technical
- Relative Strength Index (RSI)
- LCNB 44.87
- CATX 39.06
- Support Level
- LCNB $14.42
- CATX $4.66
- Resistance Level
- LCNB $14.99
- CATX $5.14
- Average True Range (ATR)
- LCNB 0.36
- CATX 0.46
- MACD
- LCNB -0.01
- CATX -0.00
- Stochastic Oscillator
- LCNB 48.96
- CATX 8.93
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.